Skip to main content

Table 1 Distribution of Type-Specific Prevalent and Persistent Cervical High-Risk (hr) HPV Infections by HIV status

From: Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection

HPV Type

Prevalent Infections

Persistent Infections

Total

n = 517

HIV Negative

n = 247

HIV Positive

n = 270

Total

n = 473

HIV Negative

n = 223

HIV Positive

n = 250

hrHPV Positive

125 (24.2%)

37 (14.9%)

88 (32.6%)

51 (10.8%)

10 (0.0%)

41 (1.8%)

HPV 16

10 (1.9%)

2 (0.8%)

8 (2.9%)

4 (0.9%)

0 (0.0%)

4 (1.6%)

HPV 18

20 (3.9%)

5 (2.0%)

15 (5.5%)

5 (1.1%)

0 (0.0%)

5 (2.0%)

HPV 31

11 (2.1%)

1 (0.4%)

10 (3.7%)

6 (1.3%)

1 (0.5%)

5 (2.0%)

HPV 33

16 (3.1%)

3 (1.2%)

13 (4.8%)

4 (0.9%)

1 (0.5%)

3 (1.2%)

HPV 35

27 (5.2%)

5 (2.0%)

22 (8.1%)

14 (3.0%)

3 (1.4%)

11 (4.4%)

HPV 39

7 (1.3%)

2 (0.8%)

5 (1.8%)

2 (0.4%)

0 (0.0%)

2 (0.8%)

HPV 45

9 (1.7%)

4 (1.6%)

5 (1.8%)

1 (0.2%)

0 (0.0%)

1 (0.4%)

HPV 51

9 (1.7%)

1 (0.4%)

8 (2.9%)

3 (0.6%)

0 (0.0%)

3 (1.2%)

HPV 52

37 (7.1%)

12 (4.8%)

25 (9.2%)

18 (3.8%)

5 (2.2%)

13 (5.2%)

HPV 56

9 (1.7%)

4 (1.6%)

5 (1.8%)

1 (0.2%)

0 (0.0%)

1 (0.4%)

HPV 58

10 (1.9%)

2 (0.8%)

8 (2.9%)

3 (0.6%)

1 (0.5%)

2 (0.8%)

HPV 59

7 (1.3%)

0 (0.0%)

7 (2.5%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

  1. The table shows the number (percentage) of participants who were high-risk HPV positive at baseline